Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Goodwill data on record, last reported at $3.4 million in Q1 2025.

  • For Q1 2025, Goodwill fell 98.96% year-over-year to $3.4 million; the TTM value through Mar 2025 reached $3.4 million, down 98.96%, while the annual FY2023 figure was $326.0 million, N/A changed from the prior year.
  • Goodwill reached $3.4 million in Q1 2025 per MRVI's latest filing, down from $326.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $326.5 million in Q2 2023 and bottomed at $3.4 million in Q1 2025.
  • Average Goodwill over 5 years is $249.2 million, with a median of $326.0 million recorded in 2023.
  • Peak YoY movement for Goodwill: fell 0.14% in 2024, then crashed 98.96% in 2025.
  • A 5-year view of Goodwill shows it stood at $152.8 million in 2021, then surged by 85.56% to $283.5 million in 2022, then grew by 14.99% to $326.0 million in 2023, then changed by 0.0% to $326.0 million in 2024, then plummeted by 98.96% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $3.4 million in Q1 2025, $326.0 million in Q2 2024, and $326.0 million in Q1 2024.